Detalles de la búsqueda
1.
Management of antithrombotic therapy in gray areas of venous thromboembolism: a Delphi consensus panel.
Intern Emerg Med
; 15(7): 1255-1264, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232785
2.
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.
Cancer Res
; 63(18): 5902-8, 2003 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14522916
3.
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.
Cancer Chemother Pharmacol
; 52(2): 131-8, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12783202
4.
Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin), an example of potential problems for extrapolation of active drug concentrations from in vitro studies.
Cancer Chemother Pharmacol
; 53(1): 89-90, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14586558
5.
Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry.
Rapid Commun Mass Spectrom
; 18(10): 1017-23, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15150823
6.
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma.
Int J Cancer
; 111(6): 961-7, 2004 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15300810
Resultados
1 -
6
de 6
1
Próxima >
>>